The concept of CRO remains hot, can the "taking medicine" trend spread?

Senior investment advisor Li Longshuan of Jianghai Securities believes that the improvement in the fundamentals of the pharmaceutical industry, coupled with policy benefits, will bring opportunities. Liu Chong, Chief Strategy Researcher of Shenzhen Android Investment Co., Ltd., believes that the fundamentals of the CRO industry have significantly improved and still have potential in the medium term. Song Zhenghao of Orient Securities believes that the development of artificial intelligence will bring efficiency improvements to the pharmaceutical industry.